CASP2 and RIPK1 Domain Containing Adaptor with Death Domain (CRADD) Peptide
CRADD
Reactivité: Humain, Souris, Rat
Hôte: Synthetic
BP
-
- Antigène Tous les produits CRADD
- CRADD (CASP2 and RIPK1 Domain Containing Adaptor with Death Domain (CRADD))
- Origine
- Humain, Souris, Rat
-
Source
- Synthetic
- Application
- Blocking Peptide (BP)
- Attributs du produit
- The peptide is used to block Anti-RAIDD Antibody reactivity.
-
-
- Indications d'application
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Stock
- -20 °C
- Stockage commentaire
- Shipped at 4°C. Store at -20°C for one year.
- Date de péremption
- 12 months
-
- Antigène
- CRADD (CASP2 and RIPK1 Domain Containing Adaptor with Death Domain (CRADD))
- Synonymes
- cradd Peptide, MGC89035 Peptide, zgc:101717 Peptide, CRADD Peptide, DKFZp468A2219 Peptide, LOC100226369 Peptide, raidd Peptide, MGC78788 Peptide, MRT34 Peptide, RAIDD Peptide, CASP2 and RIPK1 domain containing adaptor with death domain Peptide, CASP2 and RIPK1 domain containing adaptor with death, gene 1 Peptide, CASP2 and RIPK1 domain containing adaptor with death, gene 2 S homeolog Peptide, CRADD Peptide, cradd.1 Peptide, cradd Peptide, cradd.2.S Peptide, Cradd Peptide
- Sujet
- RAIDD, Death domain-containing protein CRADD, Caspase and RIP adapter with death domain, RIP-associated protein with a death domain
- ID gène
- 8738, 12905
- UniProt
- P78560, O88843
-
Vous êtes ici:
